MedPath

PAPAVERINUM-INJEEL LIQ

PAPAVERINUM-INJEEL LIQ

Discontinued
DIN Number

02073226

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

Biologische Heilmittel Heel Gmbh

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02073226
AIG Number0337005001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (3)

PAPAVERINEActive
Strength: 12 D / 1.1 ML
Monograph: PAPAVERINE
PAPAVERINEActive
Strength: 200 D / 1.1 ML
Monograph: PAPAVERINE
PAPAVERINEActive
Strength: 30 D / 1.1 ML
Monograph: PAPAVERINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.